Plain-English translation of NCT06973824 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers are collecting detailed medical, lab, and pathology information from patients who have had pituitary tumor surgery over the past 20 years. By studying this large group of patients, the team hopes to identify which characteristics—like tumor type, size, or patient age—best predict how well someone will recover and do long-term after surgery. This information could eventually help doctors give patients more accurate expectations about their own outcomes.
Pituitary tumors are rare, so doctors don't have enough reliable data to predict which patients will do well and which may have complications. By gathering 20 years of surgical outcomes in one place, researchers can finally identify the most important factors that affect how patients recover, which could improve treatment planning for future patients.
You likely qualify if…
You likely don't qualify if…
Participation involves allowing researchers to access and review your medical records, surgical reports, pathology results, and follow-up notes from your pituitary tumor treatment. Some patients may be newly enrolling (prospective), while others will have their past records reviewed (retrospective). There are no new procedures or treatments—researchers are simply gathering and analyzing information that was already collected during your regular care.
AI-generated summary from trial data · Jun 7, 2026 · Not medical advice
Italy